Ludwig Researchers Present New Findings on Combination Immunotherapy and Other Research at the 2017 ASCO … – Newswise (press release)
|
Ludwig Researchers Present New Findings on Combination Immunotherapy and Other Research at the 2017 ASCO …
Newswise (press release) Newswise — Ludwig Cancer Research released today the full scope of Ludwig’s participation at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, June 2-6. Ludwig scientists will present findings on efforts to diagnose … |
|
America’s Top Young Researchers Named Finalists for 2017 Blavatnik National Awards for Young Scientists
Newswise (press release) His group was the first to demonstrate that CRISPR-Cas9 could be harnessed for mammalian genome editing and has gone on to successfully develop CRISPR–Cpf1 (for potentially simpler and more precise genome editing) and CRISPR-C2c2 (a novel … |
Scientific American |
Trials of Embryonic Stem Cells to Launch in China
Scientific American In the next few months, surgeons in the Chinese city of Zhengzhou will carefully drill through the skulls of people with Parkinson’s disease and inject 4 million immature neurons derived from human embryonic stem cells into their brains. Then they will … |
PR Newswire (press release) |
Patient-Centered Stem Cell Therapy Bill Passed by Texas Legislature
PR Newswire (press release) LA JOLLA, Calif., May 31, 2017 /PRNewswire/ — House Bill (HB 810) on stem cell therapy has passed in the Texas legislature sending it to the Governor’s desk to sign into law. Once signed by Governor Greg Abbott, patients in Texas will have access to … What We’re Reading: Antibiotic of Last Resort; Soon-Shiong’s Appointment; Stem Therapies in TexasAJMC.com Managed Markets Network |
|
Cancer meeting to provide clues on future immunotherapy combos
Reuters As a wider range of drugs that enlist the body’s immune system to fight cancer become available, clues about which combinations will prove most effective are expected at the upcoming meeting of the American Society of Clinical Oncology. The ASCO … |